Evidence map›Paper›PMID 33794361›Full record

ArticleNeuroImage2021

Strengths and challenges of longitudinal non-human primate neuroimaging.

Xiaowei Song, Pamela García-Saldivar, Nathan Kindred, Yujiang Wang, Hugo Merchant, Adrien Meguerditchian, Yihong Yang, Elliot A Stein, Charles W Bradberry, Suliann Ben Hamed and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in NeuroImage, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Cerebral Activity in Female Baboons (Affective science · 2022
    Article
  8. Article
  9. The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiaowei SongPreclinical Pharmacology Section, Intramural Research Program, NIDA, NIH, Baltimore, MD 21224, USA.
Pamela García-SaldivarInstituto de Neurobiología, UNAM, Campus Juriquilla. Boulevard Juriquilla No. 3001 Querétaro, Qro. 76230, México.
Nathan KindredBiosciences Institute & Centre for Behaviour and Evolution, Faculty of Medical Sciences, Newcastle University, United Kingdom.
Yujiang WangCNNP Lab (www.cnnp-lab.com), Interdisciplinary Complex Systems Group, School of Computing, Newcastle University, United Kingdom.
Hugo MerchantInstituto de Neurobiología, UNAM, Campus Juriquilla. Boulevard Juriquilla No. 3001 Querétaro, Qro. 76230, México.
Adrien MeguerditchianLaboratoire de Psychologie Cognitive, UMR7290, Université Aix-Marseille/CNRS, Institut Language, Communication and the Brain 13331 Marseille, France.
Yihong YangNeuroimaging Research Branch, Intramural Research Program, NIDA, NIH, Baltimore, MD 21224, USA.
Elliot A SteinNeuroimaging Research Branch, Intramural Research Program, NIDA, NIH, Baltimore, MD 21224, USA.
Charles W BradberryPreclinical Pharmacology Section, Intramural Research Program, NIDA, NIH, Baltimore, MD 21224, USA.
Suliann Ben HamedInstitut des Sciences Cognitives Marc Jeannerod, UMR 5229, Université de Lyon - CNRS, France.
Hank P JedemaPreclinical Pharmacology Section, Intramural Research Program, NIDA, NIH, Baltimore, MD 21224, USA. Electronic address: hank.jedema@nih.gov.
Colline PoirierBiosciences Institute & Centre for Behaviour and Evolution, Faculty of Medical Sciences, Newcastle University, United Kingdom. Electronic address: colline.poirier@ncl.ac.uk.

Funding

Multimodal preclinical imaging studies of decisional determinants of drug vs non-drug choiceZIADA000622 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI JEDEMA, HANK · 2017 to 2025
$21.9M
Neuroimaging of preclinical models of substance use disordersZIADA000638 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI YANG, YIHONG · 2021 to 2025
$12.5M
Translational addiction neurobiologyZIADA000597 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI STEIN, ELLIOT A · 2013 to 2021
$6.2M
National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/K000802/1
6 · The paper itself

Abstract

Longitudinal non-human primate neuroimaging has the potential to greatly enhance our understanding of primate brain structure and function. Here we describe its specific strengths, compared to both cross-sectional non-human primate neuroimaging and longitudinal human neuroimaging, but also its associated challenges. We elaborate on factors guiding the use of different analytical tools, subject-specific versus age-specific templates for analyses, and issues related to statistical power.

Indexed as

AgingHuman DevelopmentNeuroimagingPrimatesAnimalsCross-Sectional StudiesDiffusion Tensor ImagingFunctional NeuroimagingHumansLongitudinal StudiesMagnetic Resonance ImagingAgeingDevelopmentMagnetic resonance imagingNon-human primateSimulationTemplates

Identifiers

PMID33794361
PMCPMC8270888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.